Suppr超能文献

新型喹诺酮类药物对非发酵菌的体外活性及敏感性试验参考

[In vitro activity of new quinolones against nonfermenters and references to sensitivity tests].

作者信息

Grimm H

出版信息

Infection. 1986;14 Suppl 3:S191-5. doi: 10.1007/BF01667842.

Abstract

Studies of cross resistance between norfloxacin, ofloxacin, enoxacin and ciprofloxacin using 599 strains of non-fermentative gram-negative rods (297 Pseudomonas spp. and 302 Acinetobacter spp.) resulted in nearly identical minimal inhibitory concentrations of norfloxacin and enoxacin Comparing MIC values, in most ofloxacin was one to four dilution steps superior to enoxacin, and ciprofloxacin was one to four dilution steps superior to ofloxacin. There was not much difference in MICs when species were studied in more detail. In some instances susceptibility testing with more than one new quinolone may be necessary, and evaluation criteria are given.

摘要

利用599株非发酵革兰氏阴性杆菌(297株假单胞菌属和302株不动杆菌属)对诺氟沙星、氧氟沙星、依诺沙星和环丙沙星之间的交叉耐药性进行研究,结果显示诺氟沙星和依诺沙星的最低抑菌浓度几乎相同。比较最低抑菌浓度值,在大多数情况下,氧氟沙星比依诺沙星高1至4个稀释度,环丙沙星比氧氟沙星高1至4个稀释度。当对菌种进行更详细的研究时,最低抑菌浓度没有太大差异。在某些情况下,可能需要用一种以上的新型喹诺酮进行药敏试验,并给出了评估标准。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验